Abbott Announces Supply Agreement For Needlestick Prevention Products

Article

ABBOTT PARK, IL-Abbott Laboratories has signed a supply agreement for VanishPoint needlestick prevention products. VanishPoint products use patented automated retraction technology, which reduces exposure to contaminated needles.

Once a drug injection or blood draw is complete, the needle automatically retracts from the patient into the barrel of the device.

These products will become part of Abbott's Needlestick Prevention Systems product line.

Abbott already provides hospitals and healthcare facilities with VanishPoint blood collection tube holders under an 18-month agreement and VanishPoint retractable syringes as part of a two-year contract.

Abbott's products satisfy new OSHA prevention directives and the Needlestick Safety and Prevention Act, which became law November 2000.

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Recent Videos
COVID-19 infection (Adobe Stock327378972 by rost9)
Swarm of Mosquitoes on Green Background Disease Carriers Insect Infestation  (Adobe Stock 1609688034 by Amith)
Structural detail of Hepatitis B virus on blue-green background. 3D illustration (Adobe Stock 239268660 by Destina)
© 2025 MJH Life Sciences

All rights reserved.